By Samoyed · 237
Microbiome Diversity
Brampton Clinic Offers Physiotherapy Services
By Samoyed · 271
Endocrine Balance
New Imaging Techniques Detect Brain Loss Before Symptoms
By emily johnson · 129
Microbiome Diversity
Hospitals Adopt Cost Analytics to Streamline Maternity Care
By emily johnson · 410 Views · October 16, 2026
Somatic Drills
Hospitals Urged to Scrutinize Patient Transport Vendors More Closely
By emily johnson · 124
Recovery Modalities
Healthcare Adopts Software Platforms for Seamless Data Integration
By emily johnson · 83
New Imaging Techniques Detect Brain Loss Before Symptoms
By emily johnson
Hospitals Struggle With Hidden Tech Pilot Costs
By emily johnson
Reviewing Medications at Home for Safety
By Samoyed
Hair Loss Often Treated Without Proper Assessment
By emily johnson
Waikato Homes Tackle Dampness, Stale Air with Multi-Pronged Approach
By emily johnson
Microbiome Diversity 
Microbiome Diversity 
Microbiome Diversity 
FDA Pilot Aims to Accelerate U.S. Drug Trials
0 by emily johnson
In-Depth Analysis Pharmacy Landscape in Indonesia
0 by Samoyed
Ivonescimab Meets Overall Survival Goal in NSCLC
0 by emily johnson
Public Health Teams Adopt Data Diaries for Decisions
0 by emily johnson
Recovery Modalities
Healthcare Adopts Software Platforms for Seamless Data Integration
October 12, 2026
Recovery Modalities
Simple Home Systems Help Reduce Everyday Stress
Home stress reduction comes from simple home systems that eliminate friction points like missing chargers and forgotten passwords,...
October 3, 2026
Recovery Modalities
Group finds Trump drug deals favor drugmakers over patients
Public Citizen scrutinizes the Most-Favoured Nation pricing deals between the Trump administration and 27 pharmaceutical companies, arguing claims...
September 23, 2026
Recovery Modalities
Three biotech firms eye Nasdaq listings
Three biotech firms—including ADARx Pharma—are preparing Nasdaq listings, with ADARx targeting a $1.74 billion valuation for its hereditary...
September 22, 2026
Recovery Modalities
Bayer Moves Hyrnuo Into Frontline Lung Cancer
Bayer secured FDA approval for Hyrnuo lung cancer treatment, marking a major shift in frontline HER2-mutant NSCLC care...
September 10, 2026
Editor's picks
Why Is Medicaid Member Engagement Essential for Health
Medicaid is a cornerstone of healthcare access for millions of Americans, including low-income families, seniors, and individuals with disabilities. While...
August 27, 2026
Top healthcare SaaS firms transform legacy systems with precision
Top healthcare SaaS firms transform legacy systems with precision to ensure compliance, scalability, and seamless patient data integration.
October 15, 2026
Pharma struggles as AI fraud erodes patient trust in calls
AI fraud is eroding patient trust in pharma calls, with scammers using voice cloning and spoofing to mimic legitimate pharmaceutical...
September 16, 2026
NZ health planners adopt privacy-focused geospatial guidelines
New Zealand health planners are adopting privacy-focused geospatial guidelines to map immunisation rates and service usage while safeguarding location data.
October 5, 2026
Top healthcare SaaS firms transform legacy systems with precision
By Samoyed · Oct 15, 2026
Hospitals Urged to Scrutinize Patient Transport Vendors More Closely
By emily johnson · Oct 13, 2026
Hospitals Deploy AI Chatbots to Streamline Pre-Surgery Prep
By Samoyed · Oct 7, 2026
NZ health planners adopt privacy-focused geospatial guidelines
By emily johnson · Oct 5, 2026
All Post
Somatic Drills
Pharma struggles as AI fraud erodes patient trust in calls
AI fraud is eroding patient trust in pharma calls, with scammers using voice cloning and spoofing to mimic legitimate pharmaceutical outreach.
Samoyed 157 Views September 16, 2026
Endocrine Balance
Breast cancer drug Etcamah fails first-line trial test
AstraZeneca’s breast cancer drug Etcamah failed its first-line trial, SERENA-4, raising doubts about its potential as a frontline treatment for HR-positive pati
emily johnson 259 Views September 15, 2026
Microbiome Diversity
Novo Nordisk drops name to sharpen focus amid Lilly rivalry
Novo Nordisk drops its full name to become 'Novo,' sharpening focus against Eli Lilly in weight loss and diabetes treatments amid slowing growth.
emily johnson 123 Views September 14, 2026
Nutrient Synergy
AbbVie tests new approach for menstrual migraine treatment
AbbVie’s Qulipta becomes first oral CGRP inhibitor to succeed in phase 3 menstrual migraine trials, offering hope for resistant cases.
Samoyed 124 Views September 12, 2026
Endocrine Balance
Biotechs lead fight against cancer
Biotechs lead the fight against cancer with next-generation treatments and clinical trials.
emily johnson 281 Views September 11, 2026
Recovery Modalities
Bayer Moves Hyrnuo Into Frontline Lung Cancer
Bayer secured FDA approval for Hyrnuo lung cancer treatment, marking a major shift in frontline HER2-mutant NSCLC care based on new clinical data.
Samoyed 281 Views September 10, 2026
Microbiome Diversity
Bristol Myers reports progress in multiple myeloma trial
Bristol Myers reports progress in multiple myeloma trial with arlocabtagene autoleucel showing promise.
Samoyed 110 Views September 9, 2026
Microbiome Diversity
Guidelines for e-signature use in global trials
Guidelines for e-signature use in global trials, including qualified e-signature and standard e-signature options.
emily johnson 151 Views September 8, 2026
Nutrient Synergy
Ivonescimab Meets Overall Survival Goal in NSCLC
Ivonescimab surpasses Keytruda in overall survival for NSCLC first-line treatment, demonstrating potential breakthrough in lung cancer therapy.
emily johnson 246 Views September 7, 2026
Recovery Modalities
Sensorion gets green light for HearConnex trial
Sensorion's HearConnex trial gets green light for hearing loss treatment with gene therapy SENS-601.
Samoyed 137 Views September 4, 2026